Novartis, Merck and Allergan Join Those Raising U.S. Drug Prices for 2020 Novartis, Merck and Allergan Join Those Raising U.S. Drug Prices for 2020

Novartis AG, Merck& Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the tally to 445 drugs that will cost more in 2020, according to data analyzed by healthcare research firm 3 Axis Advisors.Reuters Health Information

Source: Medscape Medical News Headlines - January 6, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news